116,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

In this timely and up-to-date book, the latest knowledge on neurological syndromes due to neurotoxicity of antineoplastic drugs is presented. The initial chapters discuss the following vital topics: - the importance of blood-brain barrier changes in cancer patients, - laboratory and clinical studies on the neurotoxicity of anticancer drugs, - and the role of cumulative toxicity of radiation therapy and chemotherapy. Clinical presentation and diagnosis of various neurological conditions related to antineoplastic chemotherapy are then also thoroughly discussed. Indispensable to the…mehr

Produktbeschreibung
In this timely and up-to-date book, the latest knowledge on neurological syndromes due to neurotoxicity of antineoplastic drugs is presented. The initial chapters discuss the following vital topics: - the importance of blood-brain barrier changes in cancer patients, - laboratory and clinical studies on the neurotoxicity of anticancer drugs, - and the role of cumulative toxicity of radiation therapy and chemotherapy. Clinical presentation and diagnosis of various neurological conditions related to antineoplastic chemotherapy are then also thoroughly discussed. Indispensable to the neuro-oncologist and useful to all physicians managing cancer patients, this book is a valuable source of current information.
Autorenporträt
One drawback of drug treatment in cancer is that it may cause neurological syndromes. This book examines how such syndromes develop and their diagnosis, as well as the toxic and therapeutic properties of certain drugs.